Sanara MedTech Inc. (SMTI) has a MoatMap StockRank of 50/100 based on Quality (63/100), Value (24/100), and Momentum (50/100) factor scores. The current signal is HOLD. Sanara MedTech has interesting wound care products but lacks the scale, established moat, and clear macro tailwinds required to justify a position in a highly concentrated global equity book.
Sanara MedTech Inc. develops and commercializes advanced wound care and surgical tissue repair products, including biologics and sophisticated wound care solutions. The company offers a proprietary product portfolio rooted in regenerative medicine, supported by clinical evidence for efficacy and a specialized sales force. Sanara MedTech is a niche player in the growing wound care market, focusing on innovative solutions for complex medical cases.
| Price | $22.72 |
| Market Cap | $218M |
| P/E (TTM) | 368.67 |
| P/E (Forward) | 40.96 |
| Price/Book | 33.31 |
| Return on Equity | 2.9% |
| Return on Invested Capital | 11.7% |
| Debt/Equity | 689.01 |
| Gross Margin | 92.9% |
| Operating Margin | 9.5% |
| Revenue Growth | 18.6% |
| Free Cash Flow | $6M |
Sanara MedTech Inc. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).